- Home
- BLDE vs KMDA Comparison
BLDE vs KMDA Comparison
Compare BLDE & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- KMDA
- Stock Information
- Founded
- BLDE 2014
- KMDA 1990
- Country
- BLDE United States
- KMDA Israel
- Employees
- BLDE N/A
- KMDA N/A
- Industry
- BLDE Aerospace
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- KMDA Health Care
- Exchange
- BLDE Nasdaq
- KMDA Nasdaq
- Market Cap
- BLDE 276.7M
- KMDA N/A
- IPO Year
- BLDE N/A
- KMDA N/A
- Fundamental
- Price
- BLDE $3.47
- KMDA $5.30
- Analyst Decision
- BLDE
- KMDA Strong Buy
- Analyst Count
- BLDE 0
- KMDA 2
- Target Price
- BLDE N/A
- KMDA $14.50
- AVG Volume (30 Days)
- BLDE 506.1K
- KMDA 18.6K
- Earning Date
- BLDE 11-06-2024
- KMDA 11-11-2024
- Dividend Yield
- BLDE N/A
- KMDA N/A
- EPS Growth
- BLDE N/A
- KMDA 230.67
- EPS
- BLDE N/A
- KMDA 0.25
- Revenue
- BLDE $238,379,000.00
- KMDA $154,574,000.00
- Revenue This Year
- BLDE $12.14
- KMDA $14.85
- Revenue Next Year
- BLDE $11.35
- KMDA $7.64
- P/E Ratio
- BLDE N/A
- KMDA $20.08
- Revenue Growth
- BLDE 25.39
- KMDA 6.01
- 52 Week Low
- BLDE $2.06
- KMDA $4.08
- 52 Week High
- BLDE $4.25
- KMDA $6.53
- Technical
- Relative Strength Index (RSI)
- BLDE 59.56
- KMDA 49.09
- Support Level
- BLDE $3.37
- KMDA $5.18
- Resistance Level
- BLDE $3.54
- KMDA $5.33
- Average True Range (ATR)
- BLDE 0.14
- KMDA 0.08
- MACD
- BLDE 0.02
- KMDA 0.01
- Stochastic Oscillator
- BLDE 82.43
- KMDA 54.17
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.